Attached files

file filename
EX-99.01 - EXHIBIT 99.01 - Inspyr Therapeutics, Inc.v418319_ex99-01.htm


 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 


 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): August 14, 2015 (August 12, 2015)


 

GENSPERA, INC.

(Exact name of registrant as specified in Charter)

 

 

Delaware   0001421204   20-0438951

(State or other jurisdiction of

incorporation or organization)

  (Commission File No.)   (IRS Employee Identification No.)

 

 

2511 N Loop 1604 W, Suite 204

San Antonio, TX 78258

(Address of Principal Executive Offices)

 

210-479-8112

(Issuer Telephone number)  

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

 

 

 

Item 8.01 Other Events.

 

On August 12, 2015, Craig Dionne, chief executive officer of GenSpera, Inc. (the “Company”) participated as a guest on Reddit’s “Ask Me Anything” at https://www.reddit.com/r/IAmA. A copy of the transcript is attached to this report as Exhibit 99.01.

 

Item 9.01 Financial Statements and Exhibits.

 

         

Exhibit

No.

 

  

Description

   
99.01   Transcript dated August 12, 2015.    
         

 

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: August 14, 2015

 

 

GenSpera, Inc.
     
By:  

/s/ Craig Dionne

   

Craig Dionne

Chief Executive Officer


 

 

 

 

INDEX OF EXHIBITS

 

Exhibit

No.

 

  

Description

   
99.01   Transcript dated August 12, 2015.